| Name | Title | Contact Details |
|---|
Built from the ground up to support computationally intensive workloads, we provide the best tools for creators leveraging powerful accelerated hardware. A traditionally costly and scarce resource, GPU compute options from mono-lithic cloud providers are extremely limited. CoreWeave provides the industry`s widest range of GPU options, allowing you to pick the perfect GPU for your use case. Thousands of GPUs are ready and waiting.
AESSEAL designs and manufactures sealing solutions for a sustainable future. We work with global customers in every major industrial sector to improve the reliability, safety and environmental performance of industrial equipment. An industry pioneer, we were founded in 1979 and operate from 231 locations in 104 countries, with a total focus on achieving exceptional quality: in terms of products, technical innovation, customer service, after sales support and care for the environment.
Club Car Wash is a family-owned express car wash company based in Missouri. Founded in 2006 as Tiger Express Wash, it rebranded to Club Car Wash in 2019. The company has rapidly expanded to become one of the largest car wash chains in the Central United States, with over 213 locations and plans for 56 more by 2025. The company specializes in fast and convenient vehicle cleaning services, including exterior washes with advanced technology and various interior cleaning options. They offer membership and subscription plans for regular customers, as well as additional detailing services at select locations. Club Car Wash has grown through both organic development and acquisitions, enhancing its service offerings and geographic reach across multiple states. Their marketing focuses on quality, speed, and customer experience, catering to a diverse customer base that includes daily commuters and fleet operators.
Cameron Ashley Building Products is a prominent omni-channel distributor specializing in roofing, insulation, siding, gypsum, and other specialty building products. The company operates over 45 distribution centers across 26 states, providing more than 4.2 million square feet of storage space. Many of these centers are strategically located near major metropolitan areas, ensuring efficient product availability. The company serves over 5,000 customers in the lumber and building materials industry, including lumberyards, building materials suppliers, and contractors. Cameron Ashley combines distribution center operations with a direct-from-manufacturer approach to enhance supply chain management. This allows them to deliver a wide range of innovative products and services tailored to market needs. Cameron Ashley also fosters a supportive work environment, offering various employee benefits and development programs to prepare future leaders in the industry.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.